Capital International Investors - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 241 filers reported holding NOVOCURE LTD in Q3 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital International Investors ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$145,427,267
-60.2%
9,004,492
+2.2%
0.04%
-58.0%
Q2 2023$365,558,822
-20.5%
8,808,932
+15.2%
0.09%
-25.4%
Q1 2023$459,991,502
-21.1%
7,648,987
-3.8%
0.12%
-24.8%
Q4 2022$583,234,567
-3.0%
7,951,648
+0.4%
0.16%
-10.3%
Q3 2022$601,517,000
+9.3%
7,916,635
+0.0%
0.18%
+16.7%
Q2 2022$550,133,000
-41.5%
7,915,165
-30.2%
0.15%
-29.9%
Q1 2022$939,947,000
+10.5%
11,345,026
+0.1%
0.21%
+18.9%
Q4 2021$850,846,000
-30.6%
11,332,005
+7.3%
0.18%
-35.7%
Q3 2021$1,226,385,000
-39.5%
10,556,816
+15.5%
0.28%
-39.5%
Q2 2021$2,028,278,000
+68.3%
9,143,742
+0.3%
0.46%
+51.8%
Q1 2021$1,205,168,000
-15.6%
9,117,624
+10.4%
0.30%
-21.8%
Q4 2020$1,428,492,000
+56.5%
8,255,270
+0.7%
0.39%
+38.3%
Q3 2020$912,583,000
+341.2%
8,198,569
+135.1%
0.28%
+314.7%
Q2 2020$206,820,000
+20.2%
3,487,688
+36.5%
0.07%
-2.9%
Q1 2020$172,103,000
+47.9%
2,555,725
+85.1%
0.07%
+75.0%
Q4 2019$116,349,000
+140.8%
1,380,675
+113.7%
0.04%
+122.2%
Q3 2019$48,323,000
+18.3%
646,2000.0%0.02%
+12.5%
Q2 2019$40,859,000
+31.3%
646,2000.0%0.02%
+23.1%
Q1 2019$31,127,000
+184.1%
646,200
+97.4%
0.01%
+160.0%
Q4 2018$10,958,000327,3000.01%
Other shareholders
NOVOCURE LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Nordwand Advisors, LLC 1,515,000$111,125,24913.86%
Invus Financial Advisors, LLC 350,884$25,737,34113.70%
HARTLINE INVESTMENT CORP/ 304,482$22,333,7555.08%
GREAT POINT PARTNERS LLC 241,000$17,677,3503.46%
Tri Locum Partners LP 72,400$5,311,0002.15%
Taylor Frigon Capital Management LLC 42,061$3,085,1741.75%
HighVista Strategies LLC 28,007$2,054,3131.22%
HAP Trading, LLC 124,500$10,2941.05%
Private Harbour Investment Management & Counsel, LLC 12,285$901,1050.99%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 32,000$2,344,0000.72%
View complete list of NOVOCURE LTD shareholders